Login or sign up
For business

Madera Therapeutics

4.0ยท 12 reviews
Average ratingGreat
4.0/ 5

Based on 12 reviews

533%
433%
333%
20%
10%
Ask AI

Ask AI about Madera Therapeutics

Generated with AI from 12 reviews on Trustburn

AI-generated from reviews on this page. Verify anything important with the company directly.

Frank Picciurro
Reviews 1

I recently tried out this company and was really impressed with their product range. The website was easy to use and I found what I needed quickly. The customer service was also excellent, very helpful and friendly staff. I will definitely be using Madera Therapeutics again in the future.

Rebecca Schwilm
Reviews 1

Madera Therapeutics is a great company to work with. Their website is user-friendly and easy to navigate. The products they offer are of high quality, and their customer service is exceptional. I highly recommend Madera Therapeutics to anyone in need of their services.

Simone Pietra
Reviews 1

I recently purchased some products from this company, and I have to say I'm impressed. The website is easy to navigate and the checkout process was quick and simple. The products I received were of high quality and worked well for me. Will definitely be recommending Madera Therapeutics to others.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website โ€” a simple way to convert your visitors into customers.

Get the widget for your site →

About Madera Therapeutics

Madera Therapeutics has identified the best-in-class, chemically novel, small molecule anti-cancer agents that act through a new mechanism of action. These drugs function via an initial disruption of mitochondrial function ultimately leading to an immune response against the cancer. Lead molecules show significant biological activity on many drug resistant cancers: triple negative breast cancer, endometrial cancer, pancreatic cancer and B-cell lymphomas, addressing umet clinical needs for large patient populations. Our technology is protected by the most extensive patent portfolio in the area.